In patients with an atherosclerotic CVD event or at intermediate to high risk for one who were on statin therapy, a novel ...

NEW ORLEANS, LA—A comparison of multiple add-ons to statin therapy has shown that the oral PCSK9 inhibitor enlicitide (Merck) outperformed several different nonstatin combinations when it came to ...

New recommendations suggest that some people should start trying to lower their cholesterol as early as age 30.

ApoB testing outperforms traditional cholesterol measures in preventing heart attacks and strokes while remaining ...

Your cholesterol levels can affect your risk of heart disease and stroke. And the longer you have high cholesterol, the ...

A routine blood test taken by millions in the U.S. each year to measure "bad" cholesterol is not the best measure to guide ...

A routine blood test taken by millions in the U.S. each year to measure “bad” cholesterol is not the best measure to guide treatment and prevent heart attacks and strokes, suggests a new Northwestern ...

A routine blood test taken by millions in the U.S. each year to measure "bad" cholesterol is not the best measure to guide ...

Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny—and what nuances do you need to know? Let’s dig in.

When I tried statin therapy as part of an experiment, I quickly developed a common side effect. But what concerned me wasn’t just the sensation of pain — it was what that pain might ...

In Part 1, Part 2, and Part 3 of this 4-part series, we covered the CKM framework (the heart–kidney–metabolic connection), ...